FY2025 · period end Dec '25 · from the 10-K filed Feb 25, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $32.67B | $28.26B | $27.56B | $21.17B | $18.61B |
| Gross Profit | $17.26B | $14.49B | $14.14B | $10.70B | $9.81B |
| Operating Income | $11.30B | $9.02B | $9.04B | $6.50B | $6.75B |
| Net Income | $9.61B | $7.57B | $7.84B | $5.62B | $5.88B |
| EPS (Diluted) | $24.71 | $19.24 | $19.89 | $14.13 | $14.34 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $50.57B | $48.59B | $39.96B | $36.30B | $30.23B |
| Total Liabilities | $30.95B | $30.11B | $26.51B | $27.49B | $20.09B |
| Stockholders' Equity | $19.61B | $18.48B | $13.45B | $8.81B | $10.14B |
| Cash & Equivalents | $12.92B | $12.74B | $7.00B | $7.27B | $6.95B |
| Total Debt | $2.71B | $3.68B | $4.63B | $3.51B | $4.08B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $12.66B | $11.17B | $5.44B | $8.49B | $10.85B |
| Capital Expenditures | $1.57B | $2.07B | $2.16B | $1.28B | $0.90B |
| Free Cash Flow | $11.08B | $9.10B | $3.29B | $7.21B | $9.95B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 52.8% | 51.3% | 51.3% | 50.5% | 52.7% |
| Operating Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% |
| Net Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Return on Equity | 50.5% | 47.4% | 70.4% | 59.4% | 49.0% |
| Return on Assets | 19.4% | 17.1% | 20.6% | 16.9% | 20.5% |
| Debt / Equity | 0.14× | 0.20× | 0.34× | 0.40× | 0.40× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001628280-26-011378 | Dec 31, 2025 | Feb 25, 2026 | Feb 25, 2026 11:06 UTC | EDGAR |
| 20-F | 0000937966-25-000009 | Dec 31, 2024 | Mar 5, 2025 | Mar 5, 2025 11:21 UTC | EDGAR |
| 20-F | 0000937966-24-000008 | Dec 31, 2023 | Feb 14, 2024 | Feb 14, 2024 11:09 UTC | EDGAR |
| 20-F | 0000937966-23-000014 | Dec 31, 2022 | Feb 15, 2023 | Feb 15, 2023 11:05 UTC | EDGAR |
| 20-F | 0000937966-22-000013 | Dec 31, 2021 | Feb 9, 2022 | Feb 9, 2022 11:24 UTC | EDGAR |
| 20-F | 0000937966-21-000007 | Dec 31, 2020 | Feb 10, 2021 | Feb 10, 2021 11:10 UTC | EDGAR |
| 20-F | 0000937966-20-000011 | Dec 31, 2019 | Feb 12, 2020 | Feb 12, 2020 11:22 UTC | EDGAR |
| 20-F | 0000937966-19-000007 | Dec 31, 2018 | Feb 6, 2019 | Feb 6, 2019 11:09 UTC | EDGAR |
Direct links to SEC EDGAR. ASML has additional filings available on the SEC site.
6 numbers ASML HOLDING NV later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·FY 2016
Notable restatementwas1.7BEUR
Revised up in a 20-F.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2016
Notable restatementwas1.7BEUR
Revised up in a 20-F.
Net Income (Loss) Attributable to Parent·FY 2016
Notable restatementwas1.5BEUR
Revised up in a 20-F. Any P/E built on the original was 5.5% too high.
Gross Profit·FY 2016
Notable restatementwas3BEUR
Revised up in a 20-F.
Net Income (Loss) Attributable to Parent·FY 2017
Notable restatementwas2.1BEUR
Revised down in a 20-F. Any P/E built on the original was 2.5% too low.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2017
Notable restatementwas2.4BEUR
Revised down in a 20-F.
ASML is not the only one.
See every restatement we've found across the market — or get an alert the next time ASML revises a number.
Restatements are detected by comparing every vintage of a fact across all of ASML HOLDING NV's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ASML's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling ASML HOLDING NV — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ASML yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ASML and publish the result to your public profile.
Ask about ASML HOLDING NV
Continue in Workspace — cited answers on ASML, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs